Gaps in cardiovascular medication taking - The tip of the iceberg

Journal of General Internal Medicine

Volumn 8, Issue 12, 1993, Pages 659-666

  Rudd, Peter ^a   Ramesh, Jaishri ^b   Bryant Koslinc, Colleen ^c   Guerrero, David ^d  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

^c ROCHE BIOSCIENCE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular disease; compliance measures; drug therapy; electronic monitoring; medication compliance; morbidity; mortality; predictors

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; PATIENT COMPLIANCE; PRESCRIPTION; PROSPECTIVE STUDY; SELF REPORT;

ADULT; AGED; ANALYSIS OF VARIANCE; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DRUG MONITORING; FEMALE; HUMAN; MALE; MIDDLE AGE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 0027433112     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/BF02598282     Document Type: Article

References (40)

1. Diagnosing patient noncompliance
2. Predicting compliance with a regimen of digoxin therapy in family practice
3. Compliance: the case for objective measurement
4. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?
5. The effect of medication compliance on the control of hypertension
6. How often is medication taken as prescribed? A novel assessment technique
7. The natural history of medication compliance in a drug trial: limitations of pill counts
8. Compliance declines between clinic visits
9. The effect of prescribed daily dose frequency on patient medication compliance
10. Dynamics of drug regimen compliance—its assessment by microprocessor-based monitoring
11. Improved compliance measures: applications in an ambulatory hypertensive drug trial
12. Resolving problems of measuring compliance with medication monitors
13. Underutilization of antihypertensive drugs and associated hospitalization
14. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers
15. Compliance in children and adults: review of studies
16. The relevance of the health belief model to Australian smokers
17. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol
18. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases
19. Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy
20. Blood pressure reduction and the risk of myocardial infarction
21. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction
22. Treatment-induced blood pressure reduction and the risk of myocardial infarction
23. Goals of antihypertensive therapy: is there a point beyond which pressure reduction is dangerous?
24. Compliance with topical pilocarpine treatment
25. Validity of standard compliance measures in glaucoma compared with an electronic eyedrop monitor
26. Monitoring compliance with antiepileptic drug therapy
27. Do patients take digoxin?
28. Long-term antiarrhythmic therapy. Problem of low drug levels and patient noncompliance
29. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly
30. Causes and effects of noncompliance in cardiac patients
31. Compliance with oral drug therapy in patients with hematologic malignancy
32. The effect of compliance with treatment on survival among patients with hematologic malignancies
33. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants
34. Noncompliance in organ transplant recipients
35. Noncompliance in organ transplant recipients
36. Circadian variation of cardiovascular disease and sympathetic activity
37. Circadian variation and triggers of onset of acute cardiovascular disease
38. Analysis of possible triggers of acute myocardial infarction (the MILIS study)
39. Compliance with medication-timing: implications from a medication trial for drug development and clinical practice
40. Issues in patient compliance: the search for therapeutic sufficiency